Preview Mode Links will not work in preview mode

Health Heroes

Feb 25, 2020

Michael Fronstin and Taryn Earley, the grandmother of a child suffering with Type 3 Gaucher's disease, discuss firsthand the caregiving challenges for this rare disease and how patient registries can help deliver new treatment innovations and better outcomes for patients.

With more than 6,000 rare diseases, Kantar Health’s debut episode coincides with Rare Disease Day 2020, and centers on the impact of Gaucher’s disease, a debilitating condition that impacts 1 in 100,000 live births and caused by a deficiency of a specific enzyme (glucocerebrosidase) in the body impacting the spleen, liver, kidneys, lungs, brain and bone marrow. In this episode, Michael and Taryn sit down with Dom Tyer from pharmaphorum, the online destination for pharmaceutical news and analysis, to discuss the impact of Gaucher’s on patients and caregivers and how the development of patient registries can help deliver new innovations in medicines and treatment, improved patient outcomes, and better quality of life for those suffering with Type 2 and type 3 Gaucher’s disease.